Abstract LB029: TIGIT deletion rescues the antitumor activity of low avidity T cells by increasing TCR signal strength

Martina Spiga(Vita-Salute San Raffaele University), Chiara Bonini(Vita-Salute San Raffaele University), Hana Algül(TUM Klinikum), Laura Perani(Vita-Salute San Raffaele University), Zulma Magnani(Vita-Salute San Raffaele University), Anna Mondino(Vita-Salute San Raffaele University), Eliana Ruggiero(Vita-Salute San Raffaele University), Samuele Ferrari(Vita-Salute San Raffaele University), Maria Pia Protti(Vita-Salute San Raffaele University), Chiara Balestrieri(Vita-Salute San Raffaele University), Neda Mohammadi(Vita-Salute San Raffaele University), Arianna Pocaterra(University of Padua), Claudio Doglioni(Vita-Salute San Raffaele University), Stefano Crippa(Vita-Salute San Raffaele University), Giovanni Tonon(Vita-Salute San Raffaele University), Giulia Di Lullo(Vita-Salute San Raffaele University), Massimo Falconi(Vita-Salute San Raffaele University), Giovanni Sitia(Vita-Salute San Raffaele University), Danilo Abbati(Vita-Salute San Raffaele University), Alessia Potenza(Vita-Salute San Raffaele University), Oronza A. Botrugno(European Institute of Oncology), Maximilian Reichert(TUM Klinikum), Luigi Naldini(Vita-Salute San Raffaele University), Stefano Beretta(The San Raffaele Telethon Institute for Gene Therapy), Barbara Camisa(Vita-Salute San Raffaele University), Chiara Iozzi(Vita-Salute San Raffaele University), Alessia Airaghi(Vita-Salute San Raffaele University), Michele Reni(San Raffaele University of Rome), Giulio Giovannoni(Vita-Salute San Raffaele University), Martina Fiumara(The San Raffaele Telethon Institute for Gene Therapy)
Cancer Research
April 25, 2025
Cited by 0


Related Papers